May 2008
 
EW WEEK Vol. 13 No. 13
· Pfizer drops trials of NicOx glaucoma drug
· RegenRx awarded patent in Hong Kong
· FDA grants request to expand Neovista’s CABERNET trial
· Bepreve demonstrates efficacy in Phase III trial

[Valid RSS]View this Issue

Would you like to receive EyeWorld Week?
 
Monthly Poll

Do you believe glistenings can become severe enough to affect a patient’s visual acuity?

Yes
No



[ Results | Polls ]

Votes:14|Comments:0
 
Resources

Ophthalmologists

Practice Managers

Consumers

NYU-ASCRS Podcasting

EyeSpaceMD

 
 
Contact Information
 
 
   
Publisher:
Donald R. Long
(Direct)703-788-5754
(Cell)703-975-7766
Contact

Design:
Graphic Designer
Julio Guerrero
703-591-2220 (ext 158)
Contact

WebMaster:
John Long
Contact


Sales Manager:
Jeff Brownstein
(Direct)703-788-5745
(Cell)703-975-7744
Contact

Production Manager/Classified Sales:
Cathy Stern
703-591-2220 (ext 130)
Contact
 
 
 


Copyright © 1997-2008 EyeWorld News Service


Visit EyeWorld.mobi for a PDA optimized experience